🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A phase II, open-label, multicenter, randomized controlled trial exploring ...
Status
Not Yet Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2025-09
Trial ID
NCT07150208
Treatments Being Tested
This study will evaluate the long-term safety, efficacy and tolerability of...
Status
Completed
Location
Takanoko Hospital /ID# 232723
Start Date
2020-06-18
Trial ID
NCT04437433
Treatments Being Tested
To assess the efficacy of intravitreal (IVT) administration of aflibercept ...
Status
Completed
Location
Multiple Locations
Start Date
2014-12-19
Trial ID
NCT02305238
Treatments Being Tested
This is a Phase II/III, randomized, double-blind, placebo-controlled, multi...
Status
Completed
Location
Stanford University Medical Center
Start Date
2017-12-08
Trial ID
NCT03231878
The purpose of this long term extension study is to assess safety, tolerabi...
Status
Terminated
Location
Meitetsu Hospital
Start Date
2010-12
Trial ID
NCT01238991
This study will evaluate the efficacy and safety of mosunetuzumab in combin...
Status
Active Not Recruiting
Location
City of Hope Comprehensive Cancer Center
Start Date
2021-10-27
Trial ID
NCT04712097
Treatments Being Tested
The purpose of this six-month treatment study is * to assess feasibility o...
Status
Completed
Location
Alabama Clinical Therapeutics, LLC
Start Date
2018-09-18
Trial ID
NCT04467697
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of Seroquel XR in sch...
Status
Terminated
Location
Research Site
Start Date
2009-02
Trial ID
NCT00852631
Treatments Being Tested
The purpose of the study is to assess the long term safety of duloxetine in...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2013-09
Trial ID
NCT01914666
Treatments Being Tested
This is a multicenter, randomized, open-label Phase 2 clinical study. It is...
Status
Recruiting
Location
Peking Union Hospital, Chinese Academy of Medical Sciences
Start Date
2024-08-29
Trial ID
NCT06552429
Treatments Being Tested